MedTrace Logo

Incidental Cancer in Familial Adenomatous Polyposis

NCT05171426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2021-12-28

No results posted yet for this study

Summary

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

Conditions

Sponsors & Collaborators

  • Dr. Ersin Arslan Education and Training Hospital

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-15
Completion
2021-02-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171426 on ClinicalTrials.gov